Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness of Offering a 2nd Booster Dose of COVID-19 Vaccine on Preventing Severe COVID-19; A Register-based Randomized Trial (RRCT)

NCT05539703 is registered in ClinicalTrials.gov with Norwegian Institute of Public Health as lead sponsor.

NCT NCT05539703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05539703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness of Offering a 2nd Booster Dose of COVID-19 Vaccine on Preventing Severe COVID-19; A Register-based Randomized Trial (RRCT)
Lead sponsor
Norwegian Institute of Public Health
Phase
Not applicable
Overall status
Withdrawn
Start date
October 31, 2022
Completion date
June 30, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19